These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1888693)
21. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients. Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317 [TBL] [Abstract][Full Text] [Related]
22. The use of confidence intervals to describe the precision of trough/peak ratios for diltiazem CD in the treatment of hypertension. Meeves SG; Park GD J Clin Pharmacol; 1994 Mar; 34(3):231-5. PubMed ID: 8021331 [TBL] [Abstract][Full Text] [Related]
23. Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics. Palatini P; Casiglia E; Graniero GR; Dorigatti F; Lotoro F; Vriz O; Pessina AC Int J Clin Pharmacol Ther; 1995 Jan; 33(1):38-42. PubMed ID: 7711991 [TBL] [Abstract][Full Text] [Related]
24. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study. Neutel JM; Smith DH; Frishman WH Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the therapeutic efficacy of delayed-action diltiazem in the treatment of mild and moderate hypertension, with ambulatory of blood pressure monitoring]. Nobre F; Oigman W Arq Bras Cardiol; 1994 Oct; 63(4):321-5. PubMed ID: 7771953 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly. Djian J; Roy M; Forette B; Lekieffre J; Luccioni R J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015 [TBL] [Abstract][Full Text] [Related]
27. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study. Lacourcière Y; Poirier L; Boucher S; Spenard J J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645 [TBL] [Abstract][Full Text] [Related]
28. The Diltiazem Different Doses Study--a dose-response study of once-daily diltiazem therapy for hypertension. Nilsson P; Lindholm LH; Hedner T J Cardiovasc Pharmacol; 1996 Apr; 27(4):469-75. PubMed ID: 8847861 [TBL] [Abstract][Full Text] [Related]
29. [Diltiazem 180 mg in delayed release formulation in mild and moderate arterial hypertension]. Serra-Pinto L; Baptista A; Rocha E Rev Port Cardiol; 1995 Apr; 14(4):303-10, 283-4. PubMed ID: 7612279 [TBL] [Abstract][Full Text] [Related]
30. Comparative effects of diltiazem sustained-release formulation and metoprolol on ambulatory blood pressure and plasma lipoproteins. Lacourcière Y; Poirier L; Boucher S; Spenard J Clin Pharmacol Ther; 1990 Sep; 48(3):318-24. PubMed ID: 2401129 [TBL] [Abstract][Full Text] [Related]
31. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension. Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639 [TBL] [Abstract][Full Text] [Related]
32. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group. Ollivier JP; Wajman A; Stalla-Bourdillon A Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759 [TBL] [Abstract][Full Text] [Related]
33. Trial of slow release diltiazem for essential hypertension in general practice. Coulter DM N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187 [TBL] [Abstract][Full Text] [Related]
34. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Pool PE; Seagren SC; Salel AF Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322 [TBL] [Abstract][Full Text] [Related]
35. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension. Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301 [TBL] [Abstract][Full Text] [Related]
36. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group. Thulin T; Hedner T; Gustafsson S; Olsson SO J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368 [TBL] [Abstract][Full Text] [Related]
37. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril. Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension. Glasser SP; Neutel JM; Gana TJ; Albert KS Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683 [TBL] [Abstract][Full Text] [Related]
39. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660 [TBL] [Abstract][Full Text] [Related]
40. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension. Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]